Live feed
Filing
SC 13D
SC 13D0001104659-21-127593·Adamas Pharmaceuticals Inc
Schedule 13D ownership disclosure
ADAMAS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00548A106
Event date: 2021-10-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,131,937
- Percent of class
- 6.8500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-127593
- Form type
- SC 13D
- Filer
- Adamas Pharmaceuticals Inc
- CIK
- CIK 1328143
- Filed
- Oct 19, 2021
- Reporting period
- Oct 11, 2021
- Description
- Schedule 13D beneficial ownership